Leveraging Sona’s uniquely biocompatible gold nanorods as immunomodulators to stimulate the immune system creating new immunity that can empower immuno-oncology therapies
Download our Brand Assets kit, including logos, leadership and project images
Company Overview, Contact Details, Leadership Bio & Project Summary
Research Group
Evaluation of SONA’s Gold Nanoparticle-Mediated Photothermal Therapy in Combination with Intralesional Immune Modulation as a novel Immuno-Oncology strategy for Colorectal Cancers, Skin Cancers and Breast Cancers.
Whitepapers & Publications
Sona Whitepapers
Supporting Scientific Research, Nanoparticles & Targeted Cancer Treatments
- The Role of Hyperthermia in the Multidisciplinary Treatment of Malignant Tumors
- Functionalized Gold Nanorods for Tumor Imaging and Targeted Therapy – PMC
- Nanomaterials | Free Full-Text | Potential of Polymeric Films Loaded with Gold Nanorods for Local Hyperthermia Applications
- Effects of differently shaped TiO2NPs (nanospheres, nanorods and nanowires) on the in vitro model (Caco-2/HT29) of the intestinal barrier | Particle and Fibre Toxicology
- Gold nanospheres and nanorods for anti-cancer therapy: comparative studies of fabrication, surface-decoration, and anti-cancer treatments - Nanoscale (RSC Publishing)
Gold Nanorods
- Multifunctional Gold Nanorod for Therapeutic Applications and Pharmaceutical Delivery Considering Cellular Metabolic Responses, Oxidative Stress and Cellular Longevity
- Point-of-Care Diagnostics in Low Resource Settings: Present Status and Future Role of Microfluidics
- Photothermal Therapy Using Gold Nanorods and Near-Infrared Light in a Murine Melanoma Model Increases Survival and Decreases Tumor
- Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects
- Fabrication of Gold Nanorods with Tunable Longitudinal Surface Plasmon Resonance Peaks by Reductive Dopamine
- Gold Nanorods: The Most Versatile Plasmonic Nanoparticles | Chemical Reviews
- Nanomaterials: An Overview of Nanorods Synthesis and Optimization |
- Spheres vs. rods: The shape of gold nanoparticles influences aggregation and deposition behavior
Latest News
Sona Provides Update on First-In-Human Clinical Trial
Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company”, “Sona”), an oncology-focused life sciences company developing innovative therapies based on its uniquely biocompatible gold nanorod technology, is pleased to provide an update on the first-in-human early feasibility study of its Targeted Hyperthermia Therapy (“THT”) cancer treatment with late-stage melanoma patients. The treatment and follow-up assessments of the first cohort of patients have now been completed and treatment on the second cohort of patients has been approved with Sona’s Chief Medical Officer arriving in Santiago this past weekend to oversee further treatments.
Subscribe to Our Newsletter
Download the Company Presentation
Biocompatible Nanoparticle Technology Being Used to Develop Cancer Therapies & Rapid Diagnostics
Store
© 2025 Sona Nanotech. All Rights Reserved.